PuSH - Publication Server of Helmholtz Zentrum München

Kahl, S.* ; Gancheva, S.* ; Strassburger, K.* ; Herder, C.* ; Machann, J. ; Kupriyanova, Y.* ; Kabisch, S.* ; Henkel, E.* ; Kantartzis, K. ; Kopf, S.* ; Kasperk, C.* ; Stefan, N. ; Pfeiffer, A.* ; Birkenfeld, A.L.* ; Roden, M.*

Empagliflozin as metabolically active compound for treatment of non-alcoholic fatty liver disease in type 2 diabetes.

Diabetologia 62, S124-S124 (2019)
Open Access Green as soon as Postprint is submitted to ZB.
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Meeting abstract
ISSN (print) / ISBN 0012-186X
e-ISSN 1432-0428
Journal Diabetologia
Quellenangaben Volume: 62, Issue: , Pages: S124-S124 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Berlin ; Heidelberg [u.a.]
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)